Ameritas Advisory Services
TEVA icon

Ameritas Advisory Services’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Ameritas Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-330
Closed -$2.9K – 2326
2023
Q1 		$2.9K Buy
+330
New +$3.26K ﹤0.01% 2306

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ameritas Advisory Services's TEVA Position: Q2 2023 in Review

Ameritas Advisory Services sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2023, closing a stake of 330 shares — an estimated $2.9K sold.

Ameritas Advisory Services first reported a position in TEVA in Q1 2023 and held it in 1 quarter. The position peaked at $2.9K in Q1 2023. 429 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • Ameritas Advisory Services reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2023 after selling out during the quarter.
  • Ameritas Advisory Services sold 330 Teva Pharmaceutical Industries Limited shares in Q2 2023, an estimated $2.9K.
  • Ameritas Advisory Services first reported a position in Teva Pharmaceutical Industries Limited in Q1 2023 and held it in 1 quarter.
  • Ameritas Advisory Services's Teva Pharmaceutical Industries Limited position peaked at $2.9K in Q1 2023.
  • 429 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2023.

Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.